Comfoderm K cream 0.1%, 15g

Composition

Composition of 100 mg cream: Active ingredient: methylprednisolone aceponate-0.1 mg (based on 100% substance); auxiliary components: macrogol 40 stearate 1.5 mg;glyceryl monostearate – 8.5 mg;potassium dihydrogen to 0.49 mg;ceramide – 0.5 mg;preservative Euxyl PE 9010 (Ethylhexylglycerin – 10%, Phenoxyethanol – 90%) 0.9 mg (in terms of Phenoxyethanol);dodecahydrate hydrogen phosphate sodium 0.01 mg;methyl ethyl ketone – 7 mg;edetate disodium 0.1 mg;octyldodecanol – 7 mg;hexidecimal – 7 mg;Dimethicone 100 cst – 1 mg;cetostearyl alcohol (stearyl alcohol – 40%, cetyl alcohol 60%) 2 mg;propylene glycol – 7 mg;purified water – up to 100 mg.

Pharmacological action

Topical glucocorticosteroid

Indications

Inflammatory skin diseases that are sensitive to topical corticosteroid therapy: atopic dermatitis, neurodermatitis, children’s eczema; true eczema; microbial eczema; simple contact dermatitis; allergic (contact) dermatitis; dyshidrotic eczema.

Contraindications

Hypersensitivity to the components of the drug; tuberculosis or syphilitic processes in the area of application of the drug;viral diseases (for example, chickenpox, shingles) in the area of application of the drug; rosacea, perioral dermatitis in the area of application of the drug; skin areas with manifestations of a reaction to vaccination; children under 4 months of age.

Side effects

the incidence of side effects is classified in accordance with the recommendations of the world health organization (who): very often (≥ 10%), often (≥ 1%, < 10%), infrequently (≥ 0.1%, the < 1%), rarely (≥ 0.01%, for < 0,1%), very rare (< 0,01%), frequency unknown (to estimate the frequency of occurrence is not possible). Skin and subcutaneous tissue disorders:  rarely perioral dermatitis, skin depigmentation, allergic reactions to the components of the drug; frequency unknown skin atrophy, telangiectasia, striae, acne-like skin changes (when using the drug for more than 4 weeks and/or on an area of 10% or more of the body surface). General disorders and disorders at the injection site:  rarely-folliculitis, hypertrichosis; very rarely-itching, burning, erythema, vesicular rash; frequency unknown-systemic effects due to absorption of glucocorticosteroid (when using the drug for more than 4 weeks and/or on an area of 10% or more of the body surface). If any of the side effects listed in the instructions get worse, or any other side effects that are not listed in the instructions are noted, you should immediately inform your doctor.

Interaction

There are no data on the interaction of Comfoderm K with other drugs/substances.

How to take, course of use and dosage

Externally. Adults and children from 4 months of age. The drug is applied 1 time a day in a thin layer on the affected areas of the skin. As a rule, the duration of continuous daily treatment with Comfoderm® K should not exceed 12 weeks for adults and 4 weeks for children. Comfoderm ® K is suitable for the treatment of subacute and acute inflammatory processes without pronounced wetting, when the process is localized both on smooth skin and on the scalp, including on the skin prone to greasiness.

Special instructions

For bacterial dermatoses / dermatomycoses, specific antibacterial or antimycotic treatment is required in addition to Comfoderm K. The cream is not intended for use in ophthalmology. It is necessary to avoid getting it on the mucous membranes and in the eyes. After external application of Comfoderm K, glaucoma may develop (for example, with high-dose therapy, due to application to the skin around the eyes or very long-term use of occlusive dressings).

Storage conditions

At a temperature not exceeding 25 °C. Keep out of reach of children.

Active ingredient

Methylprednisolone aceponate, Urea

Dosage form

cream